EN  |  FR

My Intelligent Machines’ augmented-intelligence platform reduces the cost, time, and failure rates associated with clinical trials.

With MIMs’ software-as-a-service (SaaS) solution for indication prioritization and biomarker discovery in oncology, you and your team can:

Access scientific insights to support strategic decisions on indication prioritization at pre-clinical stage

Increase success rate of clinical trials for new targeted and immune therapies

Explore new potent combined therapies

Identify early high-value biomarkers to accelerate companion test development

Predict good responders to new therapies with more than 2X higher performance than other available methodologies

Generate results at one tenth of the cost of consulting services

Complete a month’s work in a single day

Quantify future trial success to attract investment

Move therapies to the clinic faster

Work code-free in a platform designed for life scientists
Automate data management and processing
Empower teams with greater autonomy

Operate with industry-leading security and compliance
Wholly own your IP
Focus on high-value strategic activities

Sound too good to be true? It isn’t.